BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Nordic AML Group - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.namlg.org
X-WR-CALDESC:Events for Nordic AML Group
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20221030T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20231206T153000
DTEND;TZID=Europe/Paris:20231206T163000
DTSTAMP:20260516T133411
CREATED:20231201T074717Z
LAST-MODIFIED:20240316T192439Z
UID:10000005-1701876600-1701880200@www.namlg.org
SUMMARY:Webinar - Immunotherapy: a new perspective for AML maintenance treatment?
DESCRIPTION:Agenda \n[Post updated 2024-03-16] \nDownload a recorded version of the webinar using this link. \nFind the HCP guide for Ceplene on this link. \nCeplene can be ordered with the Nordic item number (Vnr.) 46 54 33\, through: \nOriola in Sweden\nTMJ in Denmark\nYour local wholesaler\, Apotek 1\, NMD and Alliance in Norway \n——————————————— \nAML patients not candidates to allotransplant: relapse risk and therapeutics (Pr Bjorn Gjertsen) \nImmunotherapy with Histamine dihydrochloride in association with low-dose interleukin-2 (HDC/IL-2) for relapse prevention (Pr Kristoffer Hellstrand) \nConceivable indications of HDC/IL-2 for post-remission in AML? (Pr Bjorn Gjertsen\, Dr Martin Jädersten\, Dr Lovisa Wennström) \nFor more info\, click here. \nFor registration\, click here.
URL:https://www.namlg.org/event/webinar-immunotherapy-a-new-perspective-for-aml-maintenance-treatment/
END:VEVENT
END:VCALENDAR